» Articles » PMID: 11344880

Barriers to Universal Prenatal HIV Testing in 4 US Locations in 1997

Overview
Specialty Public Health
Date 2001 May 10
PMID 11344880
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We determined rates of prenatal HIV testing and investigated barriers to testing.

Methods: We surveyed 1362 representative parturient women from 7 hospitals in 4 locations of the United States.

Results: Overall, 89.9% of women reported being offered HIV testing and 69.6% reported being tested. Proportions of women not offered testing differed by location (range = 5.2%-16.3%), as did proportions not tested (range = 12.2%-54.4%). Among women who perceived that their clinicians had not recommended testing, 41.7% were tested, compared with 92.8% of women who perceived a strong recommendation (P < .05). Private insurance for prenatal care was also associated with not being tested. Women gave multiple reasons for not being tested, most commonly not being at risk, having been tested recently, and the test's not being offered or recommended, cited by 55.3%, 39.1% and 11.1% of women, respectively.

Conclusions: Although most parturient women were offered a prenatal HIV test and got tested, testing proportions did not reach national goals and differed significantly by location and payment status. Concern about testing consequences was not a major barrier. Perception of clinicians' recommendations strongly influenced testing. Changing provider practices will be essential to implementing universal prenatal HIV testing.

Citing Articles

Innovation and implementation determinants of HIV testing and linkage-to-care in the U.S.: a systematic review.

Zamantakis A, Merle J, Queiroz A, Zapata J, Deskins J, Pachicano A Implement Sci Commun. 2024; 5(1):111.

PMID: 39380128 PMC: 11462864. DOI: 10.1186/s43058-024-00638-0.


Uptake and determinants for HIV postpartum re-testing among mothers with prenatal negative status in Njombe region, Tanzania.

Nungu S, Mghamba J, Rumisha S, Semali I BMC Infect Dis. 2019; 19(1):398.

PMID: 31072332 PMC: 6506942. DOI: 10.1186/s12879-019-4062-8.


The necessity of HIV testing in Iranian pregnant women and its ethical considerations.

Salari P, Azizi M J Med Ethics Hist Med. 2013; 2:1.

PMID: 23908715 PMC: 3713930.


HIV status determination among tuberculosis patients from California during 2008.

Kong D, Watt J, Marks S, Flood J J Public Health Manag Pract. 2013; 19(2):169-77.

PMID: 23358296 PMC: 4562679. DOI: 10.1097/PHH.0b013e3182550a83.


Routine prenatal HIV testing: women's concerns and their strategies for addressing concerns.

Rothpletz-Puglia P, Storm D, Burr C, Samuels D Matern Child Health J. 2011; 16(2):464-9.

PMID: 21301944 PMC: 3262134. DOI: 10.1007/s10995-011-0754-4.


References
1.
Myers E, Thompson J, Simpson K . Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstet Gynecol. 1998; 91(2):174-81. DOI: 10.1016/s0029-7844(97)00629-7. View

2.
Limata C, Schoen E, Cohen D, Black S, Quesenberry Jr C . Compliance with voluntary prenatal HIV testing in a large health maintenance organization (HMO). J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 15(2):126-30. DOI: 10.1097/00042560-199706010-00005. View

3.
Leroy V, Newell M, Dabis F, Peckham C, van de Perre P, Bulterys M . International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet. 1998; 352(9128):597-600. DOI: 10.1016/s0140-6736(98)01419-6. View

4.
Wade N, Birkhead G, Warren B, Charbonneau T, French P, Wang L . Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998; 339(20):1409-14. DOI: 10.1056/NEJM199811123392001. View

5.
Cartoux M, Msellati P, Meda N, Mandelbrot L, Leroy V, van de Perre P . Attitude of pregnant women towards HIV testing in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission Mère Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS. 1998; 12(17):2337-44. PMC: 4710787. DOI: 10.1097/00002030-199817000-00016. View